Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
MASTOPIETRO v. TREVENA INC. et al
Case Number:
2:18-cv-04426
Court:
Nature of Suit:
Other Statutes: Securities/Commodities
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
-
August 03, 2021
Trevena Settles Opioid Substitute Stock-Drop Suit For $8.5M
A Pennsylvania federal court has given its final approval to an $8.5 million settlement between Trevena Inc. and investors who say the biopharmaceutical company misled them about federal approvals for a morphine alternative.
-
May 29, 2019
2 Firms Named Lead Counsel In Trevena Stock-Drop Suit
Block & Leviton LLP and Kaufman Coren & Ress LLP were named class counsel in litigation accusing Trevena Inc. of artificially inflating its share value, a Pennsylvania federal judge decided on Wednesday, citing careless errors made by an investor represented by rival attorneys.
-
October 16, 2018
Trevena Investors Sue Over Stock Drop Tied To Drug Trials
Shareholders filed a proposed class action lawsuit against Trevena Inc. in Pennsylvania federal court Monday, alleging that the company and its officers misled investors about the U.S. Food and Drug Administration's prospects for approving the company's morphine alternative.